For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Cydex Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 54

CIPO Patents = 5

EPO Patents = 21

Trademarks = 2

Forward Citations = 509

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

James D Pipkin (26 out of 33 patents)

Gerold L Mosher (26 out of 66 patents)

Vincent D Antle (18 out of 18 patents)

4. Stephen G Machatha (13 out of 13 patents)

5. Douglas B Hecker (11 out of 11 patents)

6. Daniel Joseph Cushing (10 out of 12 patents)

7. Rupert O Zimmerer (6 out of 6 patents)

8. Rebecca L Wedel (6 out of 6 patents)

9. Karen T Johnson (6 out of 7 patents)

10. Jane A Cowee (6 out of 6 patents)

11. Diane O Thompson (5 out of 6 patents)

12. Roger A Rajewski (4 out of 23 patents)

13. Álvaro Lopes (4 out of 4 patents)

14. Daniel Monteiro (4 out of 4 patents)

15. Beau Mainous (3 out of 3 patents)

Core Competencies:

Cyclodextrin

Formulations

Sulfoalkyl Ether

Alkylated Cyclodextrin

Acetaminophen

Corticosteroid

Silymarin

Prasugrel

Clopidogrel

Nitrogen Mustard

Melphalan

DPI Formulation

54 patents: Sort by Forward Citations

1. 12698348 - Alkylated cyclodextrin compositions and processes for preparing and using the same (2026-08-04),

2. 12674005 - Alkylated cyclodextrin compositions and processes for preparing and using the same (2026-07-07),

3. 12527755 - Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin (2026-01-20),

4. 12390506 - Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same (2025-08-19),

5. 12370352 - Nasal and ophthalmic delivery of aqueous corticosteroid solutions (2025-07-29),

6. 11806402 - Sulfoalkyl ether cyclodextrin compositions (2023-11-07),

7. 11795241 - Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same (2023-10-24),

8. 11464862 - DPI formulation containing sulfoalkyl ether cyclodextrin (2022-10-11),

9. 11433082 - Composition containing sulfoalkyl ether cyclodextrin and latanoprost (2022-09-06),

10. 11382944 - Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same (2022-07-12),

11. 11208500 - Manufacturing process for cyclodextrin derivatives (2021-12-28),

12. 11020363 - Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same (2021-06-01),

13. 10940128 - Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same (2021-03-09),

14. 10864183 - Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same (2020-12-15),

15. 10851184 - Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same (2020-12-01),

Company Overview

Cydex Pharmaceuticals, Inc., based in San Diego, CA, specializes in the development of innovative cyclodextrin formulations. The company focuses on enhancing the solubility and bioavailability of various pharmaceutical compounds, including acetaminophen and corticosteroids, through advanced cyclodextrin technologies such as sulfoalkyl ether and alkylated cyclodextrins. Cydex's expertise in formulation science positions it as a key player in improving drug delivery systems and therapeutic efficacy in the pharmaceutical industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

54 Patents

#116 in San Diego, CA

#1,548 in California

#6,569 in US

#13,147 in the World

San Diego, CA, United States of America

Cydex Pharmaceuticals, Inc.

Forward Citations = 509

23 inventors:

James D Pipkin (26 out of 33 patents)

Gerold L Mosher (26 out of 66 patents)

Vincent D Antle (18 out of 18 patents)

4. Stephen G Machatha (13 out of 13 patents)

5. Douglas B Hecker (11 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cydex Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/cydex-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…